Figure 1
From: Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery Disease
TMAO levels are associated to CV-mortality in PAD. Unadjusted cumulative incidence curve for the risk of CV mortality after a competing risk analysis (Fine-Gray model), where the competing event was non-CV death, in all patients categorized according to the TMAO cutoff (>2.26 µmol/L).
